Substantial evidence has shown that GSK3β, which functions as a downstream target of AKT, can regulate both Tau phosphorylation and Aβ production in AD through the PI3K/AKT-dependent pathway (Hernandez et al., 2010). The gene discussed is GSK3B; the disease is Alzheimer disease.